An Observational Study on Long-Term Efficacy and Safety of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis (FAct)
Clinical trial NCT01483326 · COMPLETED
Trial details
- NCT number
- NCT01483326
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-12-31
- Primary completion
- 2017-06-19
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.